I Made over 200%

[Health Master]

After conducting the research, I invested in and made over 200% on (XTLB) & (EYES), short % of float has been reduced to less than 1% of outstanding shares short currently.

Now investing in (XENT), has a short % of float of 6x larger (6.25%), total of 1,050,000 shares short, so may see an even lager gain.

Ears, Nose, Throat Devices Market to reach $26BB, with cumulative impact of COVID-19 SARS CoV2 variants, bio-absorbable therapies such as Propel & Sinuva fastest growing segment.

https://www.acumenresearchandconsulting.com/ear-nose-throat-ent-devices-market

(XENT) capturing 5% of market realize $1.3BB in revenues/ 32MM Shares = 40$ per share in Revenue, at comp. 10X Sales= $200 per share

(XENT) Intersect ENT Inc.

- Positive 10 day & 50 day Moving Average
- Current Assets to Liabilities ratio attractive
- Enterprise Value is undervalued compared to peer group
- 5 Day Rounding Bottom chart + (Cup & Handle)
- Moving Average Convergence Divergence crossing higher.

Christopher Michael Lim, MSc. Health Sciences
Western University Medical

 

[LuckyMac]

Thanks for sharing. This is something ive been interested in for a while. Ill keep tabs on this

 

[Henow1969]

Thanks for sharing. This is something ive been interested in for a while. Ill keep tabs on this

After conducting the research, I invested in and made over 200% on (XTLB) & (EYES), short % of float has been reduced to less than 1% of outstanding shares short currently.

Now investing in (XENT), has a short % of float of 6x larger (6.25%), total of 1,050,000 shares short, so may see an even lager gain.

Ears, Nose, Throat Devices Market to reach $26BB, with cumulative impact of COVID-19 SARS CoV2 variants, bio-absorbable therapies such as Propel & Sinuva fastest growing segment.

https://www.acumenresearchandconsulting.com/ear-nose-throat-ent-devices-market

(XENT) capturing 5% of market realize $1.3BB in revenues/ 32MM Shares = 40$ per share in Revenue, at comp. 10X Sales= $200 per share

(XENT) Intersect ENT Inc.

- Positive 10 day & 50 day Moving Average
- Current Assets to Liabilities ratio attractive
- Enterprise Value is undervalued compared to peer group
- 5 Day Rounding Bottom chart + (Cup & Handle)
- Moving Average Convergence Divergence crossing higher.

Christopher Michael Lim, MSc. Health Sciences
Western University Medical

Thanks for sharing this great information. It is I am finding from some days and help me a lot to make some good progress in my trading.